GelStat Corporation Logo

GelStat Corporation

GSAC

(2.2)
Stock Price

0,00 USD

-1985.93% ROA

0% ROE

0x PER

Market Cap.

185.394,00 USD

-21.01% DER

0% Yield

0% NPM

GelStat Corporation Stock Analysis

GelStat Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

GelStat Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (22.31%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

The stock's low PBV ratio (0x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a minimal amount of debt (-21%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Net Profit Growth

This company has consistently achieved strong net profit growth over the past five years, demonstrating a solid financial performance and making it an appealing investment option.

5 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

6 ROA

The stock's ROA (-1985.93%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

GelStat Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

GelStat Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

GelStat Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

GelStat Corporation Revenue
Year Revenue Growth
1996 4.613.162
1997 3.310.043 -39.37%
1998 1.750.623 -89.08%
1999 1.150.373 -52.18%
2000 48.035 -2294.86%
2001 3.052 -1473.89%
2002 0 0%
2003 0 0%
2004 244.850 100%
2005 338.039 27.57%
2006 233.975 -44.48%
2007 18.178 -1187.13%
2008 18.904 3.84%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

GelStat Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 155.014 100%
2004 166.905 7.12%
2005 71.464 -133.55%
2006 38.065 -87.74%
2007 0 0%
2008 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

GelStat Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 1.204.955 100%
2007 876.036 -37.55%
2008 321.972 -172.08%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

GelStat Corporation EBITDA
Year EBITDA Growth
1996 280.287
1997 506.000 44.61%
1998 398.566 -26.96%
1999 1.898.663 79.01%
2000 -135.599 1500.2%
2001 -244.999 44.65%
2002 -1.722.916 85.78%
2003 -1.475.540 -16.77%
2004 -5.832.949 74.7%
2005 -3.472.512 -67.97%
2006 -1.761.125 -97.18%
2007 -1.039.257 -69.46%
2008 -347.824 -198.79%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

GelStat Corporation Gross Profit
Year Gross Profit Growth
1996 1.399.248
1997 1.911.594 26.8%
1998 1.389.174 -37.61%
1999 1.108.923 -25.27%
2000 36.973 -2899.28%
2001 3.052 -1111.44%
2002 0 0%
2003 0 0%
2004 -320.125 100%
2005 -16.767 -1809.26%
2006 145.518 111.52%
2007 13.081 -1012.44%
2008 14.856 11.95%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

GelStat Corporation Net Profit
Year Net Profit Growth
1996 -157.149
1997 710.416 122.12%
1998 -186.498 480.92%
1999 -1.961.083 90.49%
2000 -685.052 -186.27%
2001 -117.063 -485.2%
2002 1.462.505 108%
2003 -1.473.109 199.28%
2004 -6.222.975 76.33%
2005 -5.792.011 -7.44%
2006 -1.817.827 -218.62%
2007 -1.083.466 -67.78%
2008 -399.852 -170.97%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

GelStat Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1996 0
1997 0 0%
1998 0 0%
1999 -1 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 -1 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

GelStat Corporation Free Cashflow
Year Free Cashflow Growth
1996 -763.855
1997 193.405 494.95%
1998 -203.014 195.27%
1999 185.955 209.17%
2000 -263.064 170.69%
2001 -148.725 -76.88%
2002 -343.585 56.71%
2003 -1.294.716 73.46%
2004 -5.741.332 77.45%
2005 -2.064.087 -178.15%
2006 -500.502 -312.4%
2007 -163.632 -205.87%
2008 -36.466 -348.72%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

GelStat Corporation Operating Cashflow
Year Operating Cashflow Growth
1996 -428.945
1997 488.156 187.87%
1998 -181.069 369.6%
1999 190.888 194.86%
2000 -262.878 172.61%
2001 -148.725 -76.75%
2002 -343.585 56.71%
2003 -1.086.181 68.37%
2004 -5.649.837 80.78%
2005 -1.982.763 -184.95%
2006 -488.056 -306.26%
2007 -162.132 -201.02%
2008 -36.466 -344.61%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

GelStat Corporation Capital Expenditure
Year Capital Expenditure Growth
1996 334.910
1997 294.751 -13.62%
1998 21.945 -1243.14%
1999 4.933 -344.86%
2000 186 -2552.15%
2001 0 0%
2002 0 0%
2003 208.535 100%
2004 91.495 -127.92%
2005 81.324 -12.51%
2006 12.446 -553.41%
2007 1.500 -729.73%
2008 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

GelStat Corporation Equity
Year Equity Growth
1996 936.220
1997 1.617.601 42.12%
1998 2.118.041 23.63%
1999 465.555 -354.95%
2000 -57.377 911.4%
2001 -212.075 72.94%
2002 1.292.755 116.4%
2003 932.800 -38.59%
2004 1.447.847 35.57%
2005 -1.219.345 218.74%
2006 -1.603.410 23.95%
2007 -1.966.529 18.46%
2008 -2.185.050 10%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

GelStat Corporation Assets
Year Assets Growth
1996 2.435.849
1997 2.349.973 -3.65%
1998 2.743.952 14.36%
1999 779.345 -252.08%
2000 111.616 -598.24%
2001 299.934 62.79%
2002 1.363.165 78%
2003 1.229.372 -10.88%
2004 2.560.251 51.98%
2005 441.908 -479.36%
2006 170.035 -159.89%
2007 102.674 -65.61%
2008 46.841 -119.2%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

GelStat Corporation Liabilities
Year Liabilities Growth
1996 1.255.508
1997 732.372 -71.43%
1998 625.911 -17.01%
1999 313.790 -99.47%
2000 168.993 -85.68%
2001 512.009 66.99%
2002 70.410 -627.18%
2003 296.572 76.26%
2004 1.112.404 73.34%
2005 1.661.253 33.04%
2006 1.773.445 6.33%
2007 2.069.203 14.29%
2008 2.231.891 7.29%

GelStat Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
0x
Price To Sales Ratio
8.05x
POCF Ratio
0
PFCF Ratio
-2.17
Price to Book Ratio
0
EV to Sales
27.96
EV Over EBITDA
-1.55
EV to Operating CashFlow
-7.54
EV to FreeCashFlow
-7.54
Earnings Yield
0
FreeCashFlow Yield
-0.46
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
0
Income Quality
0
ROE
0.22
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0
EBT Per Ebit
0
Ebit per Revenue
0
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
16.1
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.24
Return on Tangible Assets
-19.86
Days Sales Outstanding
0
Days Payables Outstanding
241683.46
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
-0.21
Debt to Assets
9.8
Net Debt to EBITDA
-1.1
Current Ratio
0.01
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-0.21
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.5
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
2500
Debt to Market Cap
2.48

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

GelStat Corporation Dividends
Year Dividends Growth

GelStat Corporation Profile

About GelStat Corporation

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation is headquartered in Palm City, Florida.

CEO
Mr. Javier G. Acosta
Employee
2
Address
3557 SW Corporate Parkway
Palm City, 34990

GelStat Corporation Executives & BODs

GelStat Corporation Executives & BODs
# Name Age
1 Mr. Javier G. Acosta
Chief Executive Officer & Director
70
2 Mr. Charles F. Tarzian
Chief Marketing Advisor
70
3 Dr. Roger K. Cady M.D.
Chief Medical Advisor
70

GelStat Corporation Competitors